Abstract
Background: To compare the clinical outcomes of tubeless minimally invasive percutaneous nephrolithotomy (mPCNL) and common minimally invasive percutaneous nephrolithotomy under local anesthesia, and to explore the feasibility, safety and clinical efficacy of tubeless mPCNL under local anesthesia. Methods: Patients with PCNL who underwent local anesthesia from January 1, 2018 to November 30, 2018. The patients were divided into Group 1 (tubeless mPCNL: indwelling double J tube, no indwelling nephrostomy tube) and group 2 (common mPCNL: indwelling double J tube and nephrostomy tube). Results: In group 1, the VAS scores of 6 hours after surgery was 4.07±1.79 significantly lower than that for group 2 (6.24±1.33, P<0.05). The hospital stay for group 1 was significantly shorter than group 2 (3.15±1.42 vs 6.48±1.88 days, P<0.01). There were no significant differences in the operation time, stone removal rate, or complications. Conclusion: Tubeless mPCNL is a simple, safe and effective technique under local anesthesia that significantly reduces postoperative pain and shortens hospital stays.
Introduction
Percutaneous nephrolithotomy (PCNL) is the gold-standard treatment for renal stones larger than 20mm. Traditionally, surgeons leave a nephrostomy tube in the kidney post-procedure for drainage and hemostasis. However, this tube often causes significant postoperative pain by irritating the renal pelvis and intercostal nerves. Furthermore, the standard use of general or epidural anesthesia carries risks for certain patient populations. This study evaluates a "tubeless" approach—omitting the external drainage tube—performed under local anesthesia to improve patient recovery and comfort.
Methods and Patient Cohort
This retrospective study analyzed 135 patients treated at The Affiliated ZhuZhou Hospital, XiangYa Medical College, between January and November 2018. Patients were divided into two cohorts:
- Group 1 (Tubeless, n=68): Received an internal 5F double-J stent but no external nephrostomy tube.
- Group 2 (Common, n=67): Received both the internal stent and an 18F external nephrostomy tube.
All procedures utilized local infiltration anesthesia (1% lidocaine) and minimally invasive techniques (18F working sheath, holmium laser). The groups were well-balanced regarding age, BMI, and stone characteristics.
Results
The tubeless approach demonstrated significant advantages in postoperative recovery without sacrificing surgical efficacy.
Pain and Analgesia
The primary benefit of the tubeless technique was a reduction in pain. Visual Analogue Scale (VAS) scores 6 hours post-surgery were significantly lower in Group 1 (4.07 ± 1.79) compared to Group 2 (6.24 ± 1.33, P < 0.05). This trend continued into the first postoperative day. Consequently, fewer patients in the tubeless group required additional analgesics (6 vs. 15, P = 0.042).
Hospital Stay and Safety
The average hospital stay for the tubeless group was nearly half that of the common group (3.15 vs. 6.48 days, P < 0.01). Importantly, there were no significant differences in operation time, postoperative fever, or hemoglobin decline, indicating that the omission of the nephrostomy tube did not increase surgical risk.
Surgical Efficacy
Both groups achieved high stone clearance rates, with approximately 97% of patients in both cohorts successfully cleared of stones. There was no statistical difference in operation time, which averaged approximately 70 minutes for both groups.
Discussion and Conclusion
The study confirms that the nephrostomy tube is a major driver of postoperative morbidity. By removing it, surgeons eliminate mechanical stimulation of the subcostal nerves and irritation of the renal pelvis. Performing the procedure under local anesthesia further facilitates "rapid rehabilitation," as patients can mobilize and eat almost immediately post-surgery without the fasting requirements of general anesthesia.
While this study is limited by its retrospective nature and the exclusion of complex cases (e.g., staghorn calculi), the results strongly support tubeless mPCNL under local anesthesia as a safe, effective, and patient-friendly alternative for non-complex renal stones.
Summary updated